We found that GlyNAC supplementation significantly improved plasma concentrations of key biomarkers of inflammation (IL-6, TNFα, hsCRP) and endothelial dysfunction (sICAM1, sVCAM1and E-selectin), but accrued benefits receded after stopping GlyNAC supplementation. This evidence concerns the gene TNF and endothelial dysfunction.